Janus Henderson Group PLC Raises Stock Position in Teleflex Incorporated $TFX

Janus Henderson Group PLC increased its stake in Teleflex Incorporated (NYSE:TFX) by 2.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,246,112 shares of the medical technology company’s stock after acquiring an additional 84,754 shares during the quarter. Janus Henderson Group PLC owned approximately 9.61% of Teleflex worth $518,196,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Banque Cantonale Vaudoise increased its holdings in Teleflex by 82.5% in the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after acquiring an additional 113 shares in the last quarter. V Square Quantitative Management LLC purchased a new stake in Teleflex in the 4th quarter worth $37,000. UMB Bank n.a. increased its holdings in Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 113 shares in the last quarter. Sound Income Strategies LLC purchased a new stake in Teleflex in the 4th quarter worth $45,000. Finally, Kestra Advisory Services LLC purchased a new stake in Teleflex in the 4th quarter worth $45,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Teleflex stock opened at $125.08 on Thursday. Teleflex Incorporated has a 52-week low of $100.18 and a 52-week high of $139.67. The firm has a market capitalization of $5.54 billion, a price-to-earnings ratio of -5.49, a PEG ratio of 0.95 and a beta of 0.82. The company has a fifty day simple moving average of $129.31 and a 200-day simple moving average of $119.24. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. During the same quarter in the prior year, the firm earned $1.44 earnings per share. The company’s revenue for the quarter was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities analysts anticipate that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. Teleflex’s dividend payout ratio is currently -5.96%.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Mizuho set a $140.00 price target on shares of Teleflex in a report on Friday, May 8th. Needham & Company LLC upped their target price on shares of Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. Truist Financial reaffirmed a “hold” rating and set a $143.00 target price (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Wells Fargo & Company upped their target price on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a report on Friday, May 8th. Finally, Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and upped their target price for the stock from $135.00 to $155.00 in a report on Friday, May 8th. Four research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $146.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.